Parkside Financial Bank & Trust
BankPosition in CRL — Charles River Laboratories International, Inc.
CIK 1455267
SAINT LOUIS, MO
Position in CRL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$174,052
-$24,629 QoQ
Shares Held
1,009
+1.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $2,762,380 across 28 Diagnostics & Research names. CRL ranks #4 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
4,287 | $812,815 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,224 | $601,632 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
719 | $345,255 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
This page
|
1,009 | $174,052 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
270 | $151,709 | |
| 6 | LH |
Labcorp Holdings Inc.
|
528 | $140,874 | |
| 7 | A |
Agilent Technologies, Inc.
|
897 | $102,239 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
474 | $80,835 |
All Filings in CRL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $174,052 | 1,009 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $198,681 | 996 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $184,622 | 1,180 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $157,950 | 1,041 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $151,723 | 1,008 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $168,908 | 915 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $198,939 | 1,010 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $203,273 | 984 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $282,600 | 1,043 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $207,795 | 879 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $149,140 | 761 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $144,441 | 687 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $147,731 | 732 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $138,584 | 636 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $117,685 | 598 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $97,141 | 454 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $133,181 | 469 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $146,566 | 389 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $170,432 | 413 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $148,707 | 402 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $109,265 | 377 | Shares | Defined | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||